Ozempic, Moujaro and Similar Drugs Don't Increase Risk of Pancreatic Cancer

A large real-world study found that patients with type 2 diabetes who took a GLP-1 receptor agonist such as Ozempic or Wegovy did not have an increased risk of pancreatic cancer. This contrasts with earlier studies which found a possible increased...

January 5, 2024 Today's top story Ozempic, Moujaro and Similar Drugs Don't Increase Risk of Pancreatic Cancer A large real-world study found that patients with type 2 diabetes who took a GLP-1 receptor agonist such as Ozempic or Wegovy did not have an increased risk of pancreatic cancer. This contrasts with earlier studies which found a possible increased... Read on       Scientists Finally Figure Out Why Urine is Yellow Read ON   Always Using Salt at Mealtimes May Increase Your Kidney Disease Risk by 29% Read ON   Top 5 Cancer Screenings That Should be on Your Radar in 2024 Read ON   More top Reads       Advertisement Start a custom weight loss program Noom helps you adopt healthy habits so you can lose weight and keep it off. GET STARTED

View in browser Did a friend send you this email? Subscribe here. To see all newsletters, click here. Privacy  |  Unsubscribe Our website services, content, and products are for informational purposes only. Healthline does not provide medical advice, diagnosis, or treatment and should not be used as a substitute for medical advice from a healthcare professional. Healthline encourages you to make any treatment decisions with your healthcare professional. Healthline is owned by RVO Health. © 2024 Healthline Media LLC 275 7th Ave., 24th Floor New York, NY 10001